Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2016, Vol. 36 Issue (6): 51-56    DOI: 10.13523/j.cb.20160607
    
The Preparation of the Streptolysin O Active Recombinant Protein of Streptococcus pyogenes
YANG Si-yuan, PAN Jing-mei, WANG Shuo, DENG Kai-xuan, DENG Qiang, HUANG Xin-he, LI Xue-ru
School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China
Download: HTML   PDF(811KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

The SMART algorithing (htpp://smart.emble-heideberg.de) was used for the structural analysis of Streptolysin O (Slo) in Streptococcus pyogenes. The location of protein domain shows that Slo contains a Thiol_cytolysin domain which is composed of 461 amino acids and a transmembrane domain in the amino terminus. A pET101-GENE protein expression system was used to construct genetically engineered bacteria which only express the Thiol_cytolysin domain fusion protein. The recombinant protein was purified using Ni-NTA Resins affinity chromatography. SDS-PAGE analysis of the purified recombinant protein showed that the relative molecular weight of protein is about 50kDa as same as we predicted by bioinformation. Hemolysis testing showed that the purified recombinant protein possessed the hemolytic activity in red blood cells. In addition, the polyclonal antibody against recombinant Slo was prepared in rats. The titre of antiserum was 1 ∶128 000 detected by ELISA. Analysis of Western blot with the polyclonal antibody showed that hemolysin was detected only in culture supermentant of Streptococcus pyogenes. This result showed that recombinant protein is a specific antigen in Streptococcus pyogenes.



Key wordsRecombinant streptolysin O protein      Polyclonal antibody      Streptococcus pyogenes     
Received: 03 March 2016      Published: 25 June 2016
ZTFLH:  Q812  
  R378.12  
  R392  
Cite this article:

YANG Si-yuan, PAN Jing-mei, WANG Shuo, DENG Kai-xuan, DENG Qiang, HUANG Xin-he, LI Xue-ru. The Preparation of the Streptolysin O Active Recombinant Protein of Streptococcus pyogenes. China Biotechnology, 2016, 36(6): 51-56.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20160607     OR     https://manu60.magtech.com.cn/biotech/Y2016/V36/I6/51

[1] Debra E B. Population biology of the human restricted pathogen, Streptococcus pyogenes infection. Genetics and Evolution, 2009,9(4):581-593.
[2] Li-ping Xu, Pei-feng Li. Invasive mechanisms underlying group A streptococcal pathogenesis through human plasminogen. Chemistry of Life,2010,30(3):391-396.
[3] Carapetis J R,Steer A C,Mulholl E K,et al.The global burden of group A streptococcal diseases. Lancet Infect Dis,2005,5(11):685-694.
[4] Kai-hu Yao. the classification and drug resistance status of group A streptococcus in domestic pediatric. Chinese Journal of Practical Pediatrics,2012,27 (4):262-264.
[5] Ming-huan Zheng,Zhen-quan Jiao, Li-jie Zhang, et al. Genetic analysis of Group A Streptococcus isolates recovered during acute Glomeru lonephritis outbreaks in Guizhou province of China.Journal of Clinical Microbiology,2009, 47(3):715-720.
[6] Yang Yong-hong, Shen Xu-zhuang. Recognizing the importance of the study in group A streptococcus and its related pediatric diseases. The Journal of Clinical Pediatrics,2006, 24(6):443-444.
[7] Maghnus O'Seaghdha. Streptolysin O and its Co-Toxin NAD-glycohydrolase protect Group A streptococcus from Xenophagic Killing. Plos Pathogens,2013,6(9):1-14.
[8] Cara C Mozola, A novel cholesterol-insensitive mode of membrane binding promotes cytolysin-mediated translocation by streptolysin O. Molecular Microbiology, 2014,94(3):675-687.
[9] Jia-yun Zhong, Tao Zhang. The expression and purification of recombinant streptolysin O. Scientific Chinese,2015,9 :67-69.
[10] Qi Zhang. Clinical research of blood anti-streptolysin O in patients with ankylosing spongylitis China & Foreign Medical Treatment, 2015,4:72-73.
[11] Sun Hua, Zhang Zi-de. Expression and purification and of human hydrogen peroxidase in E.coli and identification of its biological activity. Journal of Jinan University,2014,35(2):187-191.
[12] Limbago B, Penumalli V,Brian W, et al. Role of streptolysin O in a mouse model of invasive Group A streptococcal disease. Infetion and Immunity,2000,68(11):6384-6390.
[13] Yin Zhi-kui, Deng Zhi-jian. Expression of aldolase of toxoplasma gondii and preparation of the polyclonal antibodies against this protein. Chinese Journal of Cellular and Molecular Immunology, 2011,27(10):1114-1116.
[14] Hu Shan,Ma Chao,LI Xue-ru, et al. Correlation of enolase and the maturation of SpeB in Streptococcus pyogenes. Chemical Journal of Chinese Universities,2013,4(34):886-892.
[15] Chen Xi. Review on classification and representative species of hemolysin. Chinese Agricultural Science Bulletin,2008,24(8):16-22.
[16] Susanne C F,David B Ascher. Structural studies of Streptococcuspyogenes streptolysin O provide insights into the early steps of membrane penetration. Mol Biol,2014,426:785-792.
[17] Qin Yang. Expression and purification of Tir-cytoskeleton coupling protein from E.coli O157:H7 and preparation, application of its polyclonal antibodies. Chong Qing:Chongqing Medical University,2007,46.
[18] Sun Wen, Pan Xiu-zhen. Molecular cloning, hemolytic activity, and immunological characterization of suilysin from S.suis2. Journal of Henan University(Medical Science),2014,3(33):179-184.
[19] Hisashi K, Yutaka F. Expression of recombinant streptolysin O and specific antibody production. J Mol Microbiol Biotechnol, 2005, 10:64-68.
[20] Tang Xin-jie, Sheng Ling-ling, ZHANG Qun, et al. Effects of streptolysin O on increasing cell permeability Chinese Journal of Tissue Engineering Research, 2012, 16(46): 8689-8692.
[21] Horohov D W,Loynachan A T. The use of streptolysin O(SLO) as an adjunct therapy for Rhodococcus equi pneumonia in foals.Veterinary Microbiology, 2011,154:156-162.

[1] CHEN Xiu-yue,ZHOU Wen-feng,HE Qing,SU Bing,ZOU Ya-wen. Preparation, Purification and Identification of Bacteriophage Qβ Virus-like Particles[J]. China Biotechnology, 2021, 41(7): 42-49.
[2] CHEN Qiu-li,YANG Li-chao,LI Hui,WEN Sha,LI Gang,HE Min. Prokaryotic Expression,Purification and Preparation of Polyclonal Antibody of Human Nek2 Protein[J]. China Biotechnology, 2020, 40(3): 31-37.
[3] QIN Rui-ping, LI Ling-xia, MA Xiao-ling, XI Ou-yan, ZHAO Ting, QIU Ling-ling, LI Jiang-wei. Inhibition of Osteoporosis in Ovariectomized Rats Using Follicle-stimulating Hormone Receptor Specific Polyclonal Antibody[J]. China Biotechnology, 2017, 37(6): 9-16.
[4] LIU Yan-Xia, FAN Zhen-Chuan. Polyclonal Antibody Preparation and Application of C.reinhardtii LZTFL1 Protein[J]. China Biotechnology, 2017, 37(11): 109-115.
[5] CHEN Xiao-feng, HU Pan, LI Yan-song, GUO Xing, ZOU De-ying, LIU Nan-nan, LU Shi-ying, ZHOU Yu, LIU Zeng-shan, LI Zhao-hui, REN Hong-lin. Molecular Cloning, Prokaryotic Expression and Polyclonal Antibody Preparation of Peroxiredoxin 6 (Prdx6) from Mus musculus[J]. China Biotechnology, 2016, 36(3): 11-16.
[6] LIAO He-bin, LIU Ma-feng, CHENG An-chun. The Assessment of RecA Acted as an Internal Reference Protein in R. anatipestifer[J]. China Biotechnology, 2015, 35(6): 26-31.
[7] LI Hui, XUE Wei, SUN Xue-song. Ferrichrome Binding Characteristics of Wild Type-and Mutant FtsBs in Streptococcus pyogenes[J]. China Biotechnology, 2015, 35(10): 32-38.
[8] ZHAI Tian-tian, MA Xiao-ling, Muyassar, M LI Ling-xia, LI Jiang-wei. Preparation and Characterization of Polyclonal Antibody Against CD133 Derived from Camel[J]. China Biotechnology, 2014, 34(8): 24-28.
[9] WANG Hong-cui, ZHANG Jing, XU Qian, XU Li-na, WANG Nan-jie, SUN Xue-song. The Secondery Structure Study of Iron-binding Protein MtsA from Streptococcus pyogenes[J]. China Biotechnology, 2012, 32(12): 13-19.
[10] LI Xiao, LIU Liu, ZHANG Lei, ZHOU Ya-jing. Production and Application of Polyclonal Antibody against p12, the Fourth Subunit of Human DNA Polymerase δ[J]. China Biotechnology, 2012, 32(05): 12-18.
[11] WANG Chun-hui, WANG Jian-song, WANG Wen-ju, ZHAN Hui, LI Hong-jun, YAN Ru-ping, XU Hong-yi. Preparation and Evaluation of Polyclonal Antibodies of Apoptin[J]. China Biotechnology, 2011, 31(7): 38-44.
[12] LIN Jie, MA Lan, ZHANG Shi-yi, GUAN Chang-dong, LI Xuan, LV Qi. Prokaryotic Expression of Human CD24 and Its Polyclonal Antibody Preparation[J]. China Biotechnology, 2011, 31(12): 39-45.
[13] ZHAO Jiao-hong, GAO Fu-dan, WEI Lan-zhen, WANG Quan-xi, MA Wei-min. Preparation and Preliminary Application of Polyclonal Antibody of NdhO Protein in the Cyanobacterium Synechocystis sp. Strain PCC 6803[J]. China Biotechnology, 2011, 31(06): 64-69.
[14] YANG Xiao-yan, YIN Xing-feng, ZHANG Liu-hui, HE Xiang, SUN Xue-song. Isolation and Identification of Zn2+ Binding Proteins in Streptococcus pyogenes by IMAC and LC-MS/MS[J]. China Biotechnology, 2011, 31(02): 30-37.
[15] WU Chen, GUO Xiao-dan, SONG Yu-hua, ZHANG Bo, MA Si-si, DENG Hao, GE Jian-feng, LI Shi-qi, XU Qiang, KANG Xian-jiang,. Preparation and Identification of Polyclonal Antibody Against Polypeptide N-Acetylgalactosaminyltransferase 14(GALNT14)[J]. China Biotechnology, 2011, 31(02): 74-78.